The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid
Abstract
:1. Introduction
2. Materials and Methods
2.1. Cell Culture and HT Treatment
2.2. Electron Spin Resonance Spectroscopy
2.3. Measurement of Mitochondrial ROS
2.4. Porphyrin Accumulation in Cells Treated with ALA
2.5. Western Blotting Analyses
2.6. Cellular Uptake of DOX
2.7. Cell Viability Assay
2.8. Statistical Analysis
3. Results
3.1. HT Induced Mitochondrial ROS Generation in Cancer Cells
3.2. HT Enhanced Porphyrin Synthesis in Cells Treated with ALA
3.3. Expression of ABCG2 and SLC15A1, but Not of SLC22A16, Is Regulated by HT
3.4. Intracellular DOX Accumulation Increased by HT and ALA Treatment
3.5. Combination of HT and ALA Treatment Synergistically Enhanced the Cytotoxicity of DOX
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ahmed, K.; Zaidi, S.F. Treating cancer with heat: Hyperthermia as promising strategy to enhance apoptosis. JPMA J. Pak. Med. Assoc. 2013, 63, 504–508. [Google Scholar]
- Hall, E.J.; Roizin-Towle, L. Biological effects of heat. Cancer Res. 1984, 44, 4708s–4713s. [Google Scholar]
- Song, C.W. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res. 1984, 44, 4721s–4730s. [Google Scholar] [PubMed]
- Issels, R.; Kampmann, E.; Kanaar, R.; Lindner, L.H. Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: Translation into clinical application. Int. J. Hyperth. 2016, 32, 89–95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wust, P.; Hildebrandt, B.; Sreenivasa, G.; Rau, B.; Gellermann, J.; Riess, H.; Felix, R.; Schlag, P.M. Hyperthermia in combined treatment of cancer. Lancet. Oncol. 2002, 3, 487–497. [Google Scholar] [CrossRef]
- Hildebrandt, B.; Wust, P.; Ahlers, O.; Dieing, A.; Sreenivasa, G.; Kerner, T.; Felix, R.; Riess, H. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol./Hematol. 2002, 43, 33–56. [Google Scholar] [CrossRef]
- Wessalowski, R.; Schneider, D.T.; Mils, O.; Friemann, V.; Kyrillopoulou, O.; Schaper, J.; Matuschek, C.; Rothe, K.; Leuschner, I.; Willers, R.; et al. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: An open-label, non-randomised, single-institution, phase 2 study. Lancet. Oncol. 2013, 14, 843–852. [Google Scholar] [CrossRef]
- Zhang, F.; Le, T.; Wu, X.; Wang, H.; Zhang, T.; Meng, Y.; Wei, B.; Soriano, S.S.; Willis, P.; Kolokythas, O.; et al. Intrabiliary rf heat-enhanced local chemotherapy of a cholangiocarcinoma cell line: Monitoring with dual-modality imaging--preclinical study. Radiology 2014, 270, 400–408. [Google Scholar] [CrossRef] [Green Version]
- Tschoep-Lechner, K.E.; Milani, V.; Berger, F.; Dieterle, N.; Abdel-Rahman, S.; Salat, C.; Issels, R.D. Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. N. Am. Hyperth. Group 2013, 29, 8–16. [Google Scholar] [CrossRef]
- Ohguri, T.; Imada, H.; Narisada, H.; Korogi, Y. Clinical results of systemic chemotherapy combined with regional hyperthermia. Therm. Med. (Jpn. J. Hyperthermic Oncol.) 2007, 23, 49–61. [Google Scholar] [CrossRef]
- Oxnard, G.R. The cellular origins of drug resistance in cancer. Nat. Med. 2016, 22, 232–234. [Google Scholar] [CrossRef] [PubMed]
- Robey, R.W.; Pluchino, K.M.; Hall, M.D.; Fojo, A.T.; Bates, S.E.; Gottesman, M.M. Revisiting the role of abc transporters in multidrug-resistant cancer. Nat. Rev. Cancer 2018, 18, 452–464. [Google Scholar] [CrossRef] [PubMed]
- Li, Q.; Shu, Y. Role of solute carriers in response to anticancer drugs. Mol. Cell. Ther. 2014, 2, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Beretta, G.L.; Cassinelli, G.; Pennati, M.; Zuco, V.; Gatti, L. Overcoming abc transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents. Eur. J. Med. Chem. 2017, 142, 271–289. [Google Scholar] [CrossRef] [PubMed]
- Hu, T.; Li, Z.; Gao, C.Y.; Cho, C.H. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J. Gastroenterol. 2016, 22, 6876–6889. [Google Scholar] [CrossRef]
- Wang, Y.J.; Zhang, Y.K.; Kathawala, R.J.; Chen, Z.S. Repositioning of tyrosine kinase inhibitors as antagonists of atp-binding cassette transporters in anticancer drug resistance. Cancers 2014, 6, 1925–1952. [Google Scholar] [CrossRef]
- Eid, S.Y.; El-Readi, M.Z.; Wink, M. Carotenoids reverse multidrug resistance in cancer cells by interfering with abc-transporters. Phytomed. Int. J. Phytother. Phytopharm. 2012, 19, 977–987. [Google Scholar] [CrossRef] [PubMed]
- Moitra, K. Overcoming multidrug resistance in cancer stem cells. BioMed Res. Int. 2015, 2015, 635745. [Google Scholar] [CrossRef] [Green Version]
- Zhang, W.; Fan, Y.F.; Cai, C.Y.; Wang, J.Q.; Teng, Q.X.; Lei, Z.N.; Zeng, L.; Gupta, P.; Chen, Z.S. Olmutinib (bi1482694/hm61713), a novel epidermal growth factor receptor tyrosine kinase inhibitor, reverses abcg2-mediated multidrug resistance in cancer cells. Front. Pharmacol. 2018, 9, 1097. [Google Scholar] [CrossRef] [Green Version]
- Kurokawa, H.; Ito, H.; Terasaki, M.; Matsui, H. Hyperthermia enhances photodynamic therapy by regulation of hcp1 and abcg2 expressions via high level ros generation. Sci. Rep. 2019, 9, 1638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Collaud, S.; Juzeniene, A.; Moan, J.; Lange, N. On the selectivity of 5-aminolevulinic acid-induced protoporphyrin ix formation. Curr. Med. Chemistry. Anti-Cancer Agents 2004, 4, 301–316. [Google Scholar] [CrossRef]
- Berg, K.; Selbo, P.K.; Weyergang, A.; Dietze, A.; Prasmickaite, L.; Bonsted, A.; Engesaeter, B.O.; Angell-Petersen, E.; Warloe, T.; Frandsen, N.; et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J. Microsc. 2005, 218, 133–147. [Google Scholar] [CrossRef]
- Takahashi, M.; Furihata, M.; Akimitsu, N.; Watanabe, M.; Kaul, S.; Yumoto, N.; Okada, T. A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by icam-1. Clin. Exp. Metastasis 2008, 25, 517–529. [Google Scholar] [CrossRef]
- Takahashi, M.; Miyazaki, H.; Furihata, M.; Sakai, H.; Konakahara, T.; Watanabe, M.; Okada, T. Chemokine ccl2/mcp-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model. Clin. Exp. Metastasis 2009, 26, 817–828. [Google Scholar] [CrossRef]
- Kurokawa, H.; Ito, H.; Matsui, H. Monascus purpureus induced apoptosis on gastric cancer cell by scavenging mitochondrial reactive oxygen species. J. Clin. Biochem. Nutr. 2017, 61, 189–195. [Google Scholar] [CrossRef] [Green Version]
- Buettner, G.R. The spin trapping of superoxide and hydroxyl free radicals with dmpo (5,5-dimethylpyrroline-n-oxide): More about iron. Free Radic. Res. Commun. 1993, 19 (Suppl. 1), S79–S87. [Google Scholar] [CrossRef] [Green Version]
- Ito, H.; Matsui, H.; Tamura, M.; Majima, H.J.; Indo, H.P.; Hyodo, I. Mitochondrial reactive oxygen species accelerate the expression of heme carrier protein 1 and enhance photodynamic cancer therapy effect. J. Clin. Biochem. Nutr. 2014, 55, 67–71. [Google Scholar] [CrossRef] [Green Version]
- Kurokawa, H.; Ito, H.; Matsui, H. The cisplatin-derived increase of mitochondrial reactive oxygen species enhances the effectiveness of photodynamic therapy via transporter regulation. Cells 2019, 8, 918. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ito, H.; Matsui, H.; Hirayama, A.; Indo, H.P.; Majima, H.J.; Hyodo, I. Reactive oxygen species induced by non-steroidal anti-inflammatory drugs enhance the effects of photodynamic therapy in gastric cancer cells. J. Clin. Biochem. Nutr. 2016, 58, 180–185. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ito, H.; Tamura, M.; Matsui, H.; Majima, H.J.; Indo, H.P.; Hyodo, I. Reactive oxygen species involved cancer cellular specific 5-aminolevulinic acid uptake in gastric epithelial cells. J. Clin. Biochem. Nutr. 2014, 54, 81–85. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Casas, A.; Fukuda, H.; Riley, P.; Batlle, A.M.d.C. Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. Cancer Lett. 1997, 121, 105–113. [Google Scholar] [CrossRef]
- Diez, B.; Ernst, G.; Teijo, M.J.; Batlle, A.; Hajos, S.; Fukuda, H. Combined chemotherapy and ala-based photodynamic therapy in leukemic murine cells. Leuk. Res. 2012, 36, 1179–1184. [Google Scholar] [CrossRef] [PubMed]
- Fang, H.; Zhang, Y.; Wu, Z.; Wang, X.; Wang, H.; Wang, Y.; Chai, F.; Jiang, Y.; Jin, Z.; Wan, Y.; et al. Regional hyperthermia combined with chemotherapy in advanced gastric cancer. Open Med. 2019, 14, 85–90. [Google Scholar] [CrossRef] [PubMed]
- Issels, R.D.; Lindner, L.H.; Verweij, J.; Wust, P.; Reichardt, P.; Schem, B.C.; Abdel-Rahman, S.; Daugaard, S.; Salat, C.; Wendtner, C.M.; et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: A randomised phase 3 multicentre study. Lancet Oncol. 2010, 11, 561–570. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kurokawa, H.; Matsui, H. The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid. Antioxidants 2021, 10, 1531. https://doi.org/10.3390/antiox10101531
Kurokawa H, Matsui H. The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid. Antioxidants. 2021; 10(10):1531. https://doi.org/10.3390/antiox10101531
Chicago/Turabian StyleKurokawa, Hiromi, and Hirofumi Matsui. 2021. "The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic Acid" Antioxidants 10, no. 10: 1531. https://doi.org/10.3390/antiox10101531